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Abstract
Background: The selection of an anastomosis method after a distal gastrectomy is a highly
debatable topic; however, the available documentation lacks the necessary research based on a
comparison of early postoperative complications. This study was conducted to investigate the
difference of early postoperative complications between Billroth I and Billroth II types of
anastomosis for distal gastrectomies.
Methods: A total of 809 patients who underwent distal gastrectomies for gastric cancer during
four years were included in the study. The only study endpoint was analysis of in-patients'
postoperative complications. The risk adjusted complication rate was compared by POSSUM
(Physiological and operative severity score for enumeration of morbidity and mortality) and the
severity of complications was compared by Rui Jin Hospital classification of complication.
Results: Complication rate of Billroth II type of anastomosis was almost double of that in Billroth
I (P = 0.000). Similarly, the risk adjusted complication rate was also higher in Billroth II group. More
severe complications were observed and the postoperative duration was significantly longer in
Billroth II type (P = 0.000). Overall expenditure was significantly higher in Billroth II type (P =
0.000).
Conclusion:  Billroth II method of anastomosis was associated with higher rate of early
postoperative complications. Therefore, we conclude that the Billroth I method should be the first
choice after a distal gastrectomy as long as the anatomic and oncological environment of an
individual patient allows us to perform it. However more prospective studies should be designed
to compare the overall surgical outcomes of both anastomosis methods.
Background
In the surgical approach for early and selective advanced
gastric cancer, the gastrectomy with D2 lymphadenec-
tomy was justified [1-5]. However the surgery procedures
for gastric cancer vary from one to another unit. The extent
of surgery for gastric cancer is highly heterogeneous. Cer-
tainly there are differences in morbidity rates associated
with the different extents of surgery, even though they are
all commonly denoted as radical resection [6-12]. Though
postoperative complications and the mortality rate after
gastric cancer surgery has significantly decreased over past
years, it is still considered high [13,14]. The postoperative
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complication rate was higher with inexperienced surgeons
than with experienced surgeons, and there was a consider-
able difference in early surgical outcomes among different
centers [15,16]. Postoperative complications were
inversely correlated with the volume of patients operated
on in a surgical unit [17]; the same results were published
for gastric cancer surgery [18].
There are many controversies over gastric cancer surgery,
but there are comparatively fewer articles which are dedi-
cated to early postoperative complications of gastric can-
cer surgery [14,18,19]. Therefore research on early
postoperative complications may be beneficial to give ref-
erence points that can help to optimize the success of gas-
tric cancer surgery.
There were reports of the comparison of different types of
the anastomosis method after a gastrectomy, however,
these reports were basically focused on investigating the
bile or enteric juice reflux into the gastric remnant and
esophagus following a gastrectomy. The majority of these
reports advocated for Roux-en-Y Reconstruction and some
for Billroth I (gastroduodenostomy) method of anasto-
mosis. Billroth II (gastro-jejunostomy) method was not
supported by the results of these tests [20-26].
In our clinical practice we observed that postoperative
complications were higher in the Billroth II type of anas-
tomosis, therefore we compared the early postoperative
complications of patients with the Billroth I and Billroth
II type of anastomosis. The POSSUM (physiological and
operative severity score for the enumeration of morbidity
and mortality) scoring system [27] was applied for the risk
adjusted comparison of early postoperative complications
between two groups. The POSSUM system was a valid sys-
tem to evaluate the risk adjusted comparison of surgical
outcomes in gastric cancer surgery [18,19].
First described in 1991 by Copeland et al, POSSUM was
developed as an attempt to assess the quality of surgical
care [27]. This scoring system produced assessments for
morbidity and mortality rates which did not significantly
differ from observed rates. For the development of POS-
SUM system, initially 62 individual factors were assessed
by a multivariate discriminant analysis to reduce the
number of variables. Finally, a 12-factor physiological
score(Age group, Cardiac status, ECG report, Respiratory
status, Systolic blood pressure, Pulse rate, Glasgow coma
scale, Hemoglobin, White cell count, Urea, Sodium,
Potassium) and a 6-factor operative severity score (Oper-
ative complexity, Multiple procedures, Blood loss, Perito-
neal contamination, Extent of malignant spread, Elective
or emergency surgery) were developed. Each of the factors
were graded and scored exponentially as 1, 2, 4 or 8.
Logistic regression analysis yielded statistically significant
equations for morbidity. Although the higher the overall
POSSUM score, the greater the risk of morbidity and mor-
tality, individual scores do not directly reflect the percent-
age risk [27].
Methods
The data were collected directly by the comprehensive
review of the original records of all patients. A total of 809
patients who underwent radical or palliative distal gastrec-
tomies for gastric cancer during four years was included in
the study (Table 1). Any pathology other than that of the
gastric cancer was excluded. Total gastrectomies and any
type of palliative surgery (including exploratory laparot-
omy and gastro-jejunal anastomosis) other than gastrec-
tomy were excluded. The median age of the patients was
58 years (range 17-88 years). All the patients with early
Table 1: Demographic data of the patients
Details Billroth I Billroth II
Number of patients 626 183
Age group (years) ≤60 355 100
61-70 146 39
≥71 125 44
Sex Male 394 127
Female 232 56
Type of resection Radical gastrectomy 599 160
Palliative gastrectomy 27 23
Malignancy Primary tumor 323 83
Lymph node metastasis 292 97
Distant metastasis 11 3
Automatic stapler No 403 131
Median value Yes 221 52
PS 15 15
OSS 18 18
* Including recurrent gastric cancer.BMC Cancer 2009, 9:428 http://www.biomedcentral.com/1471-2407/9/428
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and resectable advanced gastric cancer (without signifi-
cant distant metastases) underwent radical surgery (gast-
rectomies with D2 lymphadenectomy). Late stage gastric
cancer patients underwent a palliative gastrectomy.
Because of inadequate numbers of examined lymph
nodes, we could not document all the pathological data
according to the TNM classification.
The only study endpoint was the analysis of in-patients'
postoperative complications. Complications were
recorded according to the definitions mentioned in POS-
SUM [27]. However, there were a considerable number of
complications which were not covered by its definitions.
Therefore any undefined complication was recorded as
"innominate" in this study, and details were provided in
separate tables. Severities of all complications were strati-
fied according to Rui Jin Hospital Classification of Com-
plication [14,18,19]. Patients with multiple
complications were grouped into the highest level of their
respective complications, e.g. a patient with minor, mod-
erate, and severe complications was categorized into the
severe complication group (Table 2).
Statistical analysis
The statistical analysis was performed with the Statistical
Package for Social Science (SPSS) version 13.0 for Win-
dows (SPSS, Inc, Chicago, Illinois). A chi square test was
used to compare the different types of complication rates
between two groups. Non-parametric methods were used
to test the data without normal distribution. A P-value of
less than 0.05 was considered statistically significant.
Formula for risk calculation in POSSUM
Morbidity: ln R/1-R = -5.91 + (0.16 × PS) + (0.19 × OSS)
Where "R" is predicted risk. PS and OSS stands for physi-
ological score and operative severity score respectively.
The exponential analysis method was used for prediction
of morbidity rate [27]. After calculation of predicted mor-
bidity, the observed-to-predicted operative morbidity
ratio (O: E ratio) was calculated separately for Billroth I
and Billroth II group. An O: E ratio less than one implies
a performance that was better than expected, and a ratio
greater than one indicates a performance that was worse
than expected [18,19].
Results
Details of complications according to the POSSUM crite-
ria were summarized in table 3. The sum of the individual
complications was not equal to the number of total com-
plications. Multiple complications were possible in a sin-
gle patient. There was a significant difference in the
complication rate between groups of patients with Bill-
roth I and Billroth II types of anastomosis (P = 0.000). The
complication rate of the Billroth II type of anastomosis
was almost double of that in Billroth I. Incidence of differ-
ent types of postoperative infection was significantly
higher in the Billroth II type. The anastomotic leak and
mortality rate were also higher in the Billroth II type,
though there was no statistically significant difference in
those observations.
There was no significant difference of malignancy status
between Billroth I and Billroth II group (p = 0.316). But
the complication rate was significantly higher in Billroth
II than Billroth I group even after controlling the malig-
nancy status (p < 0.001). To control the effect of different
type of resection on postoperative complication, we calcu-
lated the complication rate separately for radical and pal-
liative resection. The complication rate of Billroth II was
significantly higher than Billroth I in group of patients
who underwent standard radical gastrectomy but not in
the patients who underwent palliative gastrectomy (table
4).
Moreover, the ratio of observed to estimated complication
was 1.03 for the Billroth II group while it was only 0.74 in
the Billroth I. This revealed that the surgical outcome was
poorer in the Billroth II group.
There were numerous "innominate" complications, and
most of these complications were accompanied by com-
plications described in POSSUM (table 5). The majority of
patients had pleural effusion and/or seroperitoneum.
Most of them were accompanied by a low fever but lacked
Table 2: Rui Jin Hospital classification of complications
Minor Infection: Superficial wound infection, deep infection*, chest infection*, urinary infection, septicemia, pyrexia of unknown origin*
Miscellaneous: Superficial wound dehiscence, wound hemorrhage, impaired renal function*, deep venous thrombosis *, 
Hypotension.
Moderate Infection: Deep infection†, chest infection†, pyrexia of unknown origin†.
Miscellaneous: deep wound dehiscence, impaired renal function †, deep venous thrombosis †
Innominate†
Severe Systemic: Cardiac failure, Respiratory failure, pulmonary embolus, Hypotension‡. Death
Surgical: Deep hemorrhage, deep infection‡, anastomotic leak
Innominate: complications with postop stay >30 days
*(postop ≤ 15 days), † (postop > 15 days), ‡ (Requiring laparotomy)
Except "innominate", the definition for all complications was adopted from POSSUM.BMC Cancer 2009, 9:428 http://www.biomedcentral.com/1471-2407/9/428
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a pathological diagnosis of infections. There were a sub-
stantial number of patients who had a persistent or relaps-
ing fever of unknown origin. There were a number of
patients who were clinically suspected to have a minor
anastomotic leak but lacked any objective evidence to
support it. Though these patients were settled by conserv-
ative treatments mainly nil per os, intravenous antibiotics
and total paraenteral nutrition, these cases obviously
increased the burden of the surgical ward. Other compli-
cations like pancreatic fistula, chyle leak and bleeding of
the anastomosis site were rare. Almost all types of innom-
inate complications were also higher in the Billroth II
type.
Among cases of innominate complications, some patients
did not experience any complications described in POS-
SUM. These complications were recorded empirically and
merged to calculate different levels of complication type
according to Rui Jin Hospital classification of complica-
tions. There was significant difference in severity of com-
plications between the two groups (P = 0.000). More
severe complications were observed in the Billroth II type
(fig. 1).
All of the patients were categorized into three levels
according to their postoperative stay at the hospital. There
were significant differences in the postoperative duration
between two groups of patients (P = 0.000). About 85 per-
cent of patients were discharged successfully in less than
15 days after a smooth recovery and removal of suture in
the Billroth I type (fig. 2). The postoperative duration was
significantly longer in the Billroth II type (P = 0.000).
Similarly, there was a significant difference in overall
expenditure between the two types of anastomosis
method (P = 0.000). The median expenditure value in
patients with Billroth II was 26175.26 RMB (Chinese cur-
rency) but it was only 19438.82 RMB for Billroth I (fig. 3)
Discussion
The comparison of surgical outcome is made more diffi-
cult due to a lack of standard definitions for complica-
tions and reliable auditing methods. Simply collecting
outcome data alone is not sufficient to reflect treatment
quality; because to compare postoperative complication
data directly, the original populations must be identical.
POSSUM has been proposed as a method for standardiz-
ing patient data, so direct comparisons of surgical out-
comes can be made. However there are a number of
complications (e.g., pancreatic or biliary leakage, chylus
leakage, ileus, enteroplegia and pulmonary complica-
tions) that are not defined in POSSUM [18,19]. Although
some of these complications seem to be minor, they can
Table 3: Detail of complications
Complications Billroth I Billroth II P value
Overall complication 126(20.1) 68(37.2) 0.000
Hemorrhage Deep 3(0.5) 2(1.1) NS
Wound dehiscence Superficial 2(0.3) 2(1.1) NS
Deep 4 0 NS
Anastomotic leak 8(1.3) 6(3.3) NS
Infection Wound 2(0.3) 2(1.1) NS
Deep 17(2.7) 19(10.4) 0.000
PUO* 82(13.1) 36(19.7) 0.027
Chest 17(2.7) 15(8.2) 0.001
UTI† 2(0.3) 3(1.6) NS
Multiple 10(1.6) 10(5.5) 0.003
System failure Renal 7(1.1) 4(2.2) NS
Respiratory 2(0.3) 2(1.1) NS
Cardiac 2(0.3) 1(0.5) NS
Hypotension 2(0.3) 1(0.5) NS
DVT‡ 0 1(0.5) NS
Death 1(0.2) 2(1.1) NS
*pyrexia of unknown origin, † urinary tract infection, ‡ deep venous thrombosis
Table 4: Complication rate between Billroth I and Billroth II 
reconstruction
Complication P value
Resection Anastomosis No Yes
Radical Billroth I 483(80.6) 116(19.4) < 0.001
Billroth II 99(61.9) 61(38.1)
Palliative Billroth I 17(63.0) 10(37.0) NS
Billroth II 16(69.6) 7(30.4)BMC Cancer 2009, 9:428 http://www.biomedcentral.com/1471-2407/9/428
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markedly extend the postoperative length of stay and
treatment cost and should not be ignored. Therefore POS-
SUM may need some modifications to be appropriate for
major surgical interventions.
It was a well accepted truth that the extent of surgery, espe-
cially aggressive lymph node dissection, was useless to
extend overall survival. Postoperative complications were
significantly related with the extent of surgery, especially
with the extent of lymph node dissection. This was even
proven by Japanese surgeons who reported in the New
England Journal of Medicine [15,28-30]. Therefore, gas-
tric cancer surgery should be practiced only at experienced
centers, and the extent of surgeries or procedures should
be tailored to the competence of surgeons in this field
[18]. It is imperative for non-specialized units to follow
the experience of specialized units for gastric cancer sur-
gery.
The postoperative complication rate of our hospital was
in the acceptable range. A majority of our patients had a
smooth recovery, and postoperative mortality was not
higher than previously reported data. Our hospital, which
deals with a high work volume, is a referral center for gas-
tric cancer in China. Our hospital prefers the Billroth I
method of anastomosis over the Billroth II method, and
we seldom use the Roux-en-Y method after a distal gast-
rectomy.
Table 5: Innominate complications
Complications Billroth I Billroth II P value
Pleural effusion 26(4.4) 14(7.7) NS
Consistent fever of unknown reason 55(8.8) 26(14.2) 0.032
Seroperitoneum 27(4.3) 22(12.0) 0.000
Gastro or enteroplegia 19(3.0) 14(7.7) 0.005
Pancreatitis 1(0.2) 9(4.9) 0.000
Central vein catheter infection 6(1.0) 2(1.1) NS
Anastomosis site or upper GI bleeding 1(0.2) 4(2.2) 0.010
Chyle leak 1(0.2) 1(0.5) NS
Pancreatic fistula 0 1(0.5) NS
Severity level of overall complications Figure 1
Severity level of overall complications.

























Postoperative duration at hospital Figure 2
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Our study suggests that the early postoperative complica-
tion rate is significantly lower in Billroth I group. Despite
the fact that there was not standard follow-up data, the
operative surgeons in our center feel that the long term
patients' satisfaction is also better with the Billroth I
method. The Billroth I procedure is generally simpler to
perform than other methods. It is considered to be more
physiologically sound by preserving the continuity of the
digestive tract with the duodenum and theoretically main-
taining autocrine and paracrine signaling and feedback
mechanisms [31-34]. Therefore the Billroth I type of anas-
tomosis is superior to Billroth II.
The major hurdle in selecting the Billroth I method is the
anatomic and oncological environment of the tumor. If
the tumor is more advanced and the location is more dis-
tal to the duodenum, it is difficult to perform the Billroth
I anastomosis. This is because it is difficult to obtain
tumor-free margins, and it may further increase the ten-
sion between anastomosis edges which may be associated
with higher anastomotic leak.
Interestingly enough, a higher rate of anastomotic leak
was observed in the Billroth II group of this study. The
overall complication rate was higher in the Billroth II
group, especially the infectious complications. Intra-
abdominal infection was also higher in the Billroth II
group which may be the result of higher rate of postoper-
ative pancreatitis and anastomotic leak. It may not be that
the infectious complications were simply caused by pan-
creatitis or anastomotic leakage, but certainly higher the
surgical insult or complexity of a surgery the higher will be
risk of having more complication rate including the infec-
tious complication rate. We trust the lower complication
rate in Billroth I group may be attributed to its simplicity
in terms of surgical insult and elimination of duodenal
remnant which is very prone to rupture in case of distal
obstruction or ileus. Also the early rupture of duodenal
remnant induces peripancreatic abscess or intra-abdomi-
nal infection. However a well controlled prospective study
is necessary to explore the potential factors behind the
higher rate of infectious complications and anastomotic
leaks. One can also argue that the difference in complica-
tion rate is simply the result of the inadequate surgical
experience of the surgeon who prefers Billroth I against
Billroth II, and better surgical outcome could be achieved
in centers where the Billroth II is a preferred method.
Though it was quite difficult to obtain a concrete answer
for the choice of which anastomosis method should be
preferred, the findings of this study at the very least
demand further investigation into the potential causes of
differences in surgical outcomes between the two different
types of anastomosis. This necessitates integrative
research to compare both the early and long-term aspects
of the different anastomosis methods.
If the early postoperative outcome is better with the Bill-
roth I method, it should be preferred for its simplicity and
better physiological reconstruction. However the long-
term patients' satisfaction should also be taken into con-
sideration, and operative surgeons should tailor the
appropriate method in accordance with the prognosis of
the tumor.
The Roux-en-Y method of anastomosis was advocated by
western authors [20-26] where the surgical work load was
significantly lower than eastern countries like China,
Korea and Japan. This method is not preferred in eastern
countries including our center due to its complexity and
lengthiness in comparison to the Billroth I method.
Because of a higher rate of incidence of gastric cancer in
the region, surgeons of a big hospital in eastern countries
have to deal with a huge surgical work volume [14,18].
Therefore it is wise to explore the simpler surgical meth-
ods for gastric cancer surgery which benefit both surgeons
and patients.
Conclusion
The overall postoperative complication is still higher after
gastric cancer surgery, though the severe complications
and mortality rate are lower. The Billroth II method of
anastomosis is associated with a higher rate of early post-
operative complications. Therefore we conclude that the
Billroth I method should be the first choice after a distal
gastrectomy as long as the anatomic and oncological envi-
ronment of the individual patient allows it. However
more prospective studies should be designed to compare
Difference of expenditure between two groups Figure 3
Difference of expenditure between two groups.
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the overall surgical outcomes of both anastomosis meth-
ods.
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Appendix
Definitions ofmorbidity in POSSUM system by Copeland 
et al
1. Hemorrhage: Wound hemorrhage: local haematoma
requiring evacuation. Deep hemorrhage: postoperative
bleeding requiring re-exploration.
2. Chest infection: production of purulent sputum with
positive bacteriological cultures, with or without chest
radiography changes or pyrexia, or consolidation seen on
chest radiograph.
3. Wound infection: wound cellulitis or the discharge of
purulent exudates.
4. Urinary infection: the presence of > 10 5 bacteria/ml
with the presence of white cells in the urine, in previously
clear urine.
5. Deep infection: the presence of an intra-abdominal col-
lection confirmed clinically or radiologically.
6. Septicemia: positive blood culture.
7. Pyrexia of unknown origin: any temperature above
37°C for more than 24 h occurring after the original
pyrexia following surgery (if present) had settled, for
which no obvious cause could be found
8. Wound dehiscence: superficial or deep wound break-
down.
9. Deep venous thrombosis and pulmonary embolus:
when suspected, confirmed radiologically by venography
or ventilation/perfusion scanning or diagnosed at post
mortem.
10. Cardiac failure: symptoms or signs of left ventricular
or congestive cardiac failure which required an alteration
from preoperative therapeutic measures.
11. Impaired renal function: arbitrarily defined as an
increase in blood urea of > 5 mmol/l from preoperative
levels.
12. Hypotension: a fall in systolic blood pressure below
90 mmHg for more than 2 H as determined by sphyg-
momanometer or arterial pressure transducer measure-
ment.
13. Respiratory failure: respiratory difficulty requiring
emergency ventilation.
14. Anastomotic leak: discharge of bowel content via the
drain, wound or abnormal orifice.
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